Auris Medical
19th July 2019
Auris Medical was created to exploit commercially the intellectual property PROLONG device, used to treat premature ejaculation (PE). After independent clinical trials were carried out in London University Teaching Hospitals and PROLONG was recommended as first line treatment for PE. Patent applications were made and successfully granted in 81 countries.
We were appointed by Auris to carry out a series A fund raise and were successful in securing investment from Range Capital.
